Some studies, though not explicit, identified a germline mutation involving a known susceptibility gene for pancreatic cancer (including BRCA, ATM, CDKN2A and PALB2) in patients with familial etiology20. Here, CDKN2A is linked to familial pancreatic carcinoma.